The table below presents information about our natural gas derivatives which are used to manage the risk related to significant price changes in natural gas.
| | | | | | | | | | | | | | | | |
| | As at June 30, 2024 | |
(millions of US dollars, except as otherwise noted) | | Notional 1 | | | Maturities (year) | | | Average Contract Price 2 | | | Fair Value of Assets (Liabilities) 3 | |
Derivatives not designated as hedges | | | | | | | | | | | | | | | | |
NYMEX call options | | | 29 | | | | 2024 | | | | 2.89 | | | | 6 | |
Derivatives designated as hedges | | | | | | | | | | | | | | | | |
NYMEX swaps | | | 25 | | | | 2024 | | | | 2.84 | | | | 1 | |
1 In millions of Metric Million British Thermal Units (“MMBtu”).
2 US dollars per MMBtu.
3 Fair value of natural gas derivatives are based on a discounted cash flow model which are classified as Level 2.
Our financial instruments carrying amount are a reasonable approximation of their fair values, except for our long-term debt that has a carrying value of $10,411 million and fair value of $9,774 million as of June 30, 2024. There were no transfers between levels for financial instruments measured at fair value on a recurring basis.
Note 7 Short-term debt
On March 7, 2024, we entered into an uncommitted $500 million accounts receivable repurchase facility (the “repurchase facility”), where we may sell certain receivables from customers to a financial institution and agree to repurchase those receivables at a future date. When we draw under this repurchase facility, the receivables from customers remain on our condensed consolidated balance sheet as we control and retain substantially all of the risks and rewards associated with the receivables. As at June 30, 2024, there were no borrowings made under this facility.
Note 8 Long-term debt
| | | | | | | | | | | | |
| | | |
Issuances in the second quarter of 2024 (millions of US dollars, except as otherwise noted) | | Rate of interest (%) | | | Maturity | | | Amount | |
Senior notes issued 2024 | | | 5.2 | | | | June 21, 2027 | | | | 400 | |
Senior notes issued 2024 | | | 5.4 | | | | June 21, 2034 | | | | 600 | |
| | | | | | | | | | | 1,000 | |
The notes issued in the three and six months ended June 30, 2024, are unsecured, rank equally with our existing unsecured debt, and have no sinking fund requirements prior to maturity. Each series is redeemable and has various provisions for redemption prior to maturity, at our option, at specified prices.
In March 2024, we filed a base shelf prospectus in Canada and the US qualifying the issuance of common shares, debt securities and other securities during a period of 25 months from March 22, 2024.
Note 9 Seasonality
Seasonality in our business results from increased demand for products during planting season. Crop input sales are generally higher in the spring and fall application seasons. Crop input inventories are normally accumulated leading up to each application season. The results of this seasonality have a corresponding effect on receivables from customers and rebates receivables, inventories, prepaid expenses and other current assets, and trade payables. Our short-term debt also fluctuates during the year to meet working capital requirements. Our cash collections generally occur after the application season is complete, while customer prepayments made to us are typically concentrated in December and January and inventory prepayments paid to our suppliers are typically concentrated in the period from November to January. Feed and industrial sales are more evenly distributed throughout the year.
Note 10 Related party transactions
We sell potash outside Canada and the United States exclusively through Canpotex. Canpotex sells potash to buyers, including Nutrien, in export markets pursuant to term and spot contracts at agreed upon prices. Our total revenue is recognized at the amount received from Canpotex representing proceeds from their sale of potash, less net costs of Canpotex.
| | | | | | | | |
| | |
As at (millions of US dollars) | | June 30, 2024 | | | December 31, 2023 | |
Receivables from Canpotex | | | 206 | | | | 162 | |
35